Literature DB >> 11114695

The effect of transcutaneous electric nerve stimulation in patients with therapy-resistant hypertension.

F Jacobsson1, A Himmelmann, A Bergbrant, A Svensson, C Mannheimer.   

Abstract

OBJECTIVES: Afferent nerve stimulation, such as acupuncture and transcutaneous electric nerve stimulation (TENS), has shown a blood pressure reduction in both animal and man. In the present open and non-controlled study we investigated the effect on 24-h ambulatory blood pressure of low frequency TENS in a group of hypertensive subjects who do not respond properly to pharmacological treatment.
METHOD: Twelve patients were investigated. The patients were treated with TENS at two acupoints on both forearms for 30 min twice daily during 4 weeks. 24-hour ambulatory blood pressure monitoring was recorded 1 week before, at start, at the end and finally 1 week after the TENS treatment.
RESULTS: The blood pressure did not change significantly during the run-in period. After 4 weeks of TENS, the mean systolic blood pressure decreased by 6.3 mm Hg (P < 0.05) and the mean diastolic blood pressure decreased by 3.7 mm Hg (P < 0.05). The blood pressure reduction remained unchanged 1 week after treatment. There was no change in mean heart rate.
CONCLUSION: The present study suggests that continuous TENS may have additional blood pressure-lowering properties in hypertensive patients who do not respond properly to pharmacological treatment. The effect of TENS may also have a prolonged effect. Journal of Human Hypertension (2000) 14, 795-798

Entities:  

Mesh:

Year:  2000        PMID: 11114695     DOI: 10.1038/sj.jhh.1001112

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

1.  Effects of electrical stimulation of acupuncture points on blood pressure.

Authors:  John Zhang; Derek Ng; Amy Sau
Journal:  J Chiropr Med       Date:  2009-03

2.  Effect of electroacupuncture stimulation on expression of angiotensinogen, angiotensin II type 1 receptor, endothelin-1, and endothelin a receptor mRNA in spontaneously hypertensive rat aorta.

Authors:  Ze-Jun Huo; Dong Li; Jia Guo; Sai Li; Ning Ding; Zhi-Xin Li
Journal:  Chin J Integr Med       Date:  2016-07-13       Impact factor: 1.978

3.  Transcutaneous electrical acupoint stimulation for stage 1 hypertension: protocol for a randomized controlled pilot trial.

Authors:  Zhong-Xue Tian; Cun-Zhi Liu; You-Sheng Qi; Jian-Feng Tu; Ying Lin; Yu Wang; Jing-Wen Yang; Guang-Xia Shi; Jun-Hong Liu; Li-Qiong Wang
Journal:  Trials       Date:  2020-06-22       Impact factor: 2.279

4.  Smart phone-based transcutaneous electrical acupoint stimulation as adjunctive therapy for hypertension (STAT-H trial): protocol for a cluster randomised controlled trial.

Authors:  Jian-Feng Tu; Si-Bo Kang; Li-Qiong Wang; Shi-Yan Yan; Chao-Qun Yan; Xin-Tong Su; Guang-Xia Shi; Bao-Hong Mi; Ying Lin; Yu Wang; He-Wen Li; Xue-Zhou Wang; Xiao Wang; Jing-Wen Yang; Cun-Zhi Liu
Journal:  BMJ Open       Date:  2022-07-28       Impact factor: 3.006

5.  Home-based transcutaneous electrical acupoint stimulation for high-normal blood pressure: A randomized controlled trial.

Authors:  Yu Wang; Jing-Wen Yang; Jun-Hong Liu; You-Sheng Qi; Jian-Feng Tu; Zhong-Xue Tian; Guang-Xia Shi; Shi-Yan Yan; Li-Qiong Wang; Cun-Zhi Liu
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-07-04       Impact factor: 2.885

6.  Effects of different frequencies of transcutaneous electrical nerve stimulation on venous vascular reactivity.

Authors:  O S Franco; F S Paulitsch; A P C Pereira; A O Teixeira; C N Martins; A M V Silva; R D M Plentz; M C Irigoyen; L U Signori
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590

7.  Attenuation of hypertension by C-fiber stimulation of the human median nerve and the concept-based novel device.

Authors:  Se Kyun Bang; Yeonhee Ryu; Suchan Chang; Chae Kwang Im; Jong Han Bae; Young Seob Gwak; Chae Ha Yang; Hee Young Kim
Journal:  Sci Rep       Date:  2018-10-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.